Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Angiogenesis for Peripheral Artery Occlusive Disease Using Hyaluronan Combined With Autologous Bone Marrow Cell Therapy -- Phase I/II Safety and Efficacy Study

NCT03214887 is registered in ClinicalTrials.gov with Academia Sinica, Taiwan as lead sponsor.

NCT NCT03214887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03214887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Angiogenesis for Peripheral Artery Occlusive Disease Using Hyaluronan Combined With Autologous Bone Marrow Cell Therapy -- Phase I/II Safety and Efficacy Study
Lead sponsor
Academia Sinica, Taiwan
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 17, 2017
Completion date
July 27, 2018
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral arterial occlusive disease